The stock jumped 47% to a high of $2.44 in early trading. Shares haven't traded this high since February 2023 and hit a low of 44 cents in November of that year. The producer of Playboy magazine said ...

Samsung Bioepis' Q1 2025 report shows oncology, ophthalmology, and pegfilgrastim biosimilars have gained significant market share, while immunology, filgrastim, epoetin alfa, and insulin glargine ...